Skip to main content

We earn commissions from the providers listed here. No provider buys a position, a rating, or a listing. The order is set by hand, and we do not claim it is independent of what we earn. Advertising Disclosure

Manytreatments
Manytreatments
BrowseCategoriesCompareMedicationsBy State
TreatmentsWeight LossED TreatmentHair LossTRT
AboutFAQContact
CategoriesCompareMedicationsBy StateWeight LossED TreatmentHair LossTRTHow We Rate

manytreatments

Compare telehealth providers for weight loss, erectile dysfunction, hair loss, TRT, women's health, mental health, and premature ejaculation treatment. Find pricing, reviews, and licensed US doctors in all 50 states.

Trustpilot
Google Safe Browsing verified site

Treatments

  • Weight Loss
  • ED Treatment
  • TRT
  • Hair Loss
  • Women's Health
  • PE Treatment
  • Mental Health
  • View All Treatments →

Top Brands

  • Hims
  • Medvi
  • Ro
  • Shed
  • Eden
  • Sesame Care
  • Maximus
  • Peter MD
  • View All Brands →

Resources

  • Compare Brands
  • Browse by State
  • Medications
  • Tools
  • Guides
  • Cost Guides
  • Statistics & Price Indexes
  • FAQ
  • About Us
  • Contact Us
  • How We Rate
  • Sitemap

Legal

  • Privacy Policy
  • Terms of Service
  • Affiliate Disclosure
  • Medical Disclaimer
  • Editorial Policy
  • Cookie Policy
  • California Privacy Notice (CCPA)
  • Accessibility Statement

Follow Us

  • Medium
  • YouTube
  • LinkedIn
  • Twitter/X
  • Instagram
  • Threads
© 2026 ManyTreatments.com. All rights reserved.Advertising DisclosureWe may earn commissions from affiliate links.

Content is for informational purposes only and is not medical advice. Compounded medications are not FDA-approved for safety, effectiveness, or quality. Medical Disclaimer

  1. Home
  2. Compare
  3. Medvi vs Fridays
Eric GoldWritten by Eric GoldEditor-in-Chief
Updated onOctober 07, 2026
Medvi telehealth platform
Medvi
VS
Fridays telehealth platform
Fridays
Visit MedviVisit Fridays

Medvi vs Fridays

Complete 2026 Comparison for Weight Loss

Weight Loss

Our Verdict

MEDVi's weight-loss label is $299 per month ongoing with $179 for the first month, verified 2026-09-12. Fridays, verified the same day, is $150 per month prepaid or $249 per month month-to-month for compounded semaglutide. So Fridays is cheaper on both tiers, by $149 and $50 against MEDVi's ongoing figure. MEDVi carries an FDA warning letter citing misbranding, issued 2026-02-20; our Fridays file holds none. We score both 9.2 out of 10, which settles nothing.

Pick Medvi

You want insurance kept entirely out of it and support beyond the prescription. MEDVi publishes a flat cash price of $299 per month ongoing as of 2026-09-12, carries no separate membership charge in our record, and includes free dietician visits and care coaching with a metabolic report in our fit notes. Read the FDA's warning letter to MEDVi, LLC, issued 2026-02-20, before you decide.

Pick Fridays

The monthly figure is what matters. Fridays undercuts MEDVi's ongoing price on both of its tiers, at $150 per month prepaid and $249 per month month-to-month as of 2026-09-12, and it employs an insurance concierge to work on your coverage rather than asking you to pay cash and forget insurance exists.

Fridays is cheaper on both tiers against MEDVi's $299 ongoing figure, by $149 prepaid and $50 month-to-month, both checked 2026-09-12. MEDVi's $179 is a first month and not a price. MEDVi carries an FDA warning letter citing misbranding and Fridays has nothing on that record with us, while our editorial scores tie at 9.2.

Top Weight Loss Providers

Our Top Choice
1
TrimRx logo

GLP-1 Weight Loss From $179/mo - Free 2-Minute Assessment

  • Compounded GLP-1 (semaglutide) from $179/mo, GLP-1 + GIP (tirzepatide) from $259/mo
  • Brand-name Ozempic®, Mounjaro®, Zepbound® and Wegovy® also available
  • Free 2-minute qualification quiz and FREE doctor consultation - no cost, no obligation
  • Free tracked shipping straight to your door after approval
TrimRx displays LegitScript certificate 31417191, checked September 19, 2026Cert. 31417191September 19, 2026
9.4
OutstandingScore based on review by ManyTreatments editors, popularity, brand reputation, features and benefitsLearn how we score
★★★★★
See PricingRead full review
Most Popular
2
Medvi logo

No Separate Membership Fee Listed on the Compounded Semaglutide Plan (Checked Sep 2026)

  • Doctor-guided compounded GLP-1 care, 100% online. Compounded medications are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness, or quality.
  • Free dietician visits and care coaching included with your plan
  • Doctor-formulated plans adjusted as your body responds
  • Fast, discreet shipping to your door
LegitScript lists Medvi as certified, checked on LegitScript's status page September 20, 2026CertifiedSeptember 20, 2026
9.2
OutstandingScore based on review by ManyTreatments editors, popularity, brand reputation, features and benefitsLearn how we score
★★★★★
See PricingRead full review
3
Fridays logo

Compounded Semaglutide From $150/mo on Prepaid Plans

  • Compounded semaglutide from $150/mo, tirzepatide from $240/mo on prepaid plans
  • Insurance concierge works to maximize your coverage
  • GLP-1 microdosing option and a custom plan in under 3 minutes
Fridays displays LegitScript certificate 18528873, checked September 19, 2026Cert. 18528873September 19, 2026
9.2
OutstandingScore based on review by ManyTreatments editors, popularity, brand reputation, features and benefitsLearn how we score
★★★★★
See PricingRead full review

Provider Overview

Medvi logo
9.2

Our editorial rating 9.2/10Trustpilot: 4.3/5 from 15,167 reviews, checked Nov 1, 2026

Medvi prescribes compounded GLP-1 weight loss medications through licensed US providers, bundling dietician visits and care coaching into a flat monthly price. Compounded drugs are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness, or quality.

Rating9.2/10
Free ConsultationYes
Free ShippingYes
HSA/FSAYes
Founded2023
HQUnited States
Visit MedviRead Full Review
Fridays logo
9.2

Our editorial rating 9.2/10Trustpilot: 4.1/5 from 5,192 reviews, checked Nov 1, 2026

Fridays is a GLP-1 weight loss telehealth platform offering compounded semaglutide from $150/mo and tirzepatide, plus brand-name Ozempic and Zepbound, with an insurance concierge, FSA/HSA eligibility, and bundled dietitian and coaching support.

Rating9.2/10
Free ConsultationYes
Free ShippingYes
HSA/FSAYes
Founded2023
HQUnited States
Visit FridaysRead Full Review
VS

Feature Comparison

Feature comparison between Medvi and Fridays
FeatureMedviMedviFridaysFridays
Rating9.2/109.2/10
Founded20232023
Free ConsultationYesYes
Free ShippingYesYes
Accepts InsuranceNoNo
HSA/FSA AcceptedYesYes
Mobile AppNoNo
Consultation TypeVideo, AsynchronousAsynchronous
Shipping Time3-5 business days3-5 business days

Pricing Comparison

Pricing comparison between Medvi and Fridays across treatment categories
TreatmentMedviFridays
Weight Loss$299/month$150/month

Prices shown are starting costs. Actual pricing varies by treatment plan and medication.

Pros and Cons

Medvi

Pros

  • Introductory pricing at $179 first month
  • Free dietician visits included
  • Ongoing care coaching between refills
  • All-inclusive cash pricing
  • Simple 3-step onboarding flow

Cons

  • Price increases to $299/month after first month
  • Does not accept insurance
  • Newer company with limited reviews
  • Weight loss only focus
Fridays

Pros

  • Compounded semaglutide from $150/mo on a prepaid plan
  • Both compounded and brand-name medications available
  • Insurance concierge to maximize coverage
  • FSA/HSA approved
  • Bundled dietitians, coaching, and support groups
  • GLP-1 microdosing option

Cons

  • $150/mo requires a prepaid plan; month-to-month is $249/mo
  • Compounded medications are not FDA-approved
  • Broad wellness brand rather than a single focus
  • Best pricing rewards long plans

Which Should You Choose?

MedviChoose Medvi if you:
  • Patients seeking complete GLP-1 program
  • Those wanting metabolic insights
  • Patients preferring personalized coaching
  • First-time GLP-1 users wanting guidance
Visit Medvi
FridaysChoose Fridays if you:
  • Value-seekers who want low compounded GLP-1 pricing
  • People without GLP-1 insurance coverage
  • Those who want bundled coaching and accountability
  • Anyone wanting a microdosing on-ramp
Visit Fridays

Who This Is For

This is for
  • You want to compare medication options, monthly costs, and state availability across multiple telehealth providers.
  • You prefer reviewing licensed provider programs independently before committing to a subscription.
  • The FDA-approved labeling for Wegovy and Zepbound covers weight reduction in adults with a BMI of 30 or higher, and in adults with a BMI of 27 or higher who have at least one weight-related condition such as type 2 diabetes or high blood pressure. If you are near either number, ask a licensed provider where you fall before choosing a platform.
  • If you are pregnant or planning a pregnancy, the Wegovy label directs you to stop semaglutide once pregnancy is recognized and two months before a planned pregnancy, so raise it at intake.
  • If you are breastfeeding, ask the provider what the label for the specific medication says, because the labels differ.
  • If you have a history of disordered eating, tell the provider at intake, because it is part of what a prescriber weighs before starting a weight loss medication.
  • If you have had bariatric surgery or are considering it, tell the provider at intake, because it changes what a prescriber will consider.
  • A remote visit cannot include a physical exam or in-office testing. If that matters for your situation, raise it with a licensed provider before choosing a platform.
  • If this is an emergency, call 911 or go to the nearest emergency room. Telehealth is not for emergency care.

These notes are not a medical screening: a licensed provider decides after an intake review whether a treatment is appropriate for you.

About This Comparison

Our Editorial Standards

This medvi vs fridays provider comparison is independently researched by our editorial team. We compare telehealth services based on publicly available information including pricing, available treatments, and service areas. Our ratings are editorial judgments, not tallies of reviews.

Independent Research: We do not accept payment for rankings or favorable reviews
Affiliate Disclosure: We may earn commissions from qualifying purchases at no extra cost to you
Regular Updates: Content is reviewed and updated monthly for accuracy
Licensed Providers Only: All listed services employ US-licensed healthcare providers

Not Medical Advice: This comparison is for informational purposes only. We are not healthcare providers. Always consult with a licensed physician before starting any treatment. Read our full medical disclaimer and editorial policy.

Independent ResearchNo paid placements
Fact-Checked InformationVerified against official sources
Regularly UpdatedLast updated October 7, 2026
Licensed Providers OnlyAll listed services are US-licensed

MEDVi and Fridays: the first-month figure, and the letter on one side

Eric GoldWritten by Eric GoldEditor-in-Chief
9 min readUpdated October 7, 2026

Table of Contents

Two things decide this page and neither is the number in the advertising. First, MEDVi's $179 is a first month and the months after it are $299, so budgeting against $179 budgets against the wrong figure. Second, MEDVi has an FDA warning letter on its record, which the agency's index still shows with no response letter and no close-out letter, and our Fridays file holds none. The prices below were both verified on the same day, 2026-09-12, which is rarer than it sounds and makes this one of the cleaner like-for-like reads we can offer.

The $179 is a first month, and the months after it are $299

MEDVi's published label reads $299 per month ongoing, with $179 for the first month. We verified that on 2026-09-12. The floor, meaning the figure that describes the arrangement you will actually be in from month two onward, is $299. MEDVi's listing leads with the first month, and our record holds no separate membership charge on top of it.
Both halves of that can be true at once, and we are not calling the promotion misleading. We are saying which number to plan around. An introductory month is a discount on a starting point, not a price, and the only honest way to compare it against a rival is to compare the ongoing figures.
Fridays, verified on the same date, publishes compounded semaglutide at $150 per month on a prepaid plan and $249 per month month-to-month, with compounded tirzepatide at $240 per month prepaid and $359 per month month-to-month. Against MEDVi's $299, that is a $149 gap if you prepay with Fridays and a $50 gap if you do not.
Each of those is a floor: the lowest configuration we could verify on 2026-09-12, not a quote, and not a prediction of your invoice.
  • MEDVi: $299 per month ongoing, $179 first month, as of 2026-09-12
  • Fridays compounded semaglutide: $150 prepaid, $249 month-to-month, as of 2026-09-12
  • Fridays compounded tirzepatide: $240 prepaid, $359 month-to-month, as of 2026-09-12
  • Gap against MEDVi's ongoing figure: $149 prepaid, $50 month-to-month

The federal letter sits on one side of this page

On 2026-02-20 the FDA issued MEDVi, LLC a warning letter citing misbranding, MARCS-CMS 721455, under sections 502(a) and 502(bb) of the Federal Food, Drug, and Cosmetic Act. Reviewing medvi.io in December 2025, the agency said labels bearing the MEDVi name implied that MEDVi compounds the drugs when it does not, and that two lines on the site asserted an equivalence between its compounded product and named brand-name medicines, which implies an approval a compounded drug does not hold.
We searched FDA's warning letter index for MEDVi, LLC on 2026-10-07: the entry for MARCS-CMS 721455 listed no response letter and no close-out letter. The letter is published at https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/medvi-llc-dba-medvi-721455-02202026 and you can read it yourself in a few minutes, which we would rather you did than take our summary of it.
One complication worth stating plainly. MEDVi says medvi.io is affiliate-operated rather than company-operated. We could not verify that, and the letter is addressed to MEDVi, LLC.
Our Fridays file holds no FDA warning letter. The absence of a record in our data is not a clearance and it is not a verdict about Fridays' marketing. It means we hold nothing on that record.

A dietician on one side, an insurance concierge on the other

MEDVi's feature list says free dietician visits and care coaching are included with the plan, that the care is doctor-guided and fully online, that plans are adjusted as your body responds, and that shipping is fast and discreet. Our fit notes add a metabolic report and one-to-one guidance, and describe the offer as a flat cash price with no insurance involved.
Fridays points the other way. Its feature list says an insurance concierge works to maximise your coverage, and names a GLP-1 microdosing option and a custom plan built in under three minutes. So one of these companies is designed to keep insurance out of the transaction and the other employs somebody to chase it. Which of those you want is a practical question about your own coverage rather than a quality judgement about either.
On the microdosing option, we will say only that Fridays lists it. Any decision about dose belongs to the clinician who writes your prescription, and nothing on this page should be read as guidance on that.
Both routes compared here are compounded. Compounded medications are not FDA-approved as finished drug products: the FDA has not reviewed them for safety, quality or effectiveness.

We score both 9.2, so the tie has to break somewhere else

Our editorial score is 9.2 out of 10 for MEDVi and 9.2 out of 10 for Fridays, both labelled Outstanding. That is a tie, it is our own assessment rather than anyone else's, and it is useless as a tiebreaker here.
On Trustpilot, MEDVi shows 4.3 and Fridays shows 4.2, both observed on 2026-09-11. A tenth of a point is not a difference you should act on either.
So the separations that actually exist on this page are the two we opened with. One company publishes an ongoing price of $299 and a cheaper first month; the other publishes $150 or $249 depending on commitment. One has an FDA warning letter on its record, which the agency's index still shows with no response letter and no close-out letter, and the other has nothing on that record with us. Those are the facts to weigh, and this page does not weigh them for you.

How We Compared Medvi vs Fridays

How we put this page together

Everything above was read from our own live record for MEDVi and Fridays on 2026-10-07. Nothing was recalled, averaged or inferred.

Prices are floors carrying the date we checked them, and both brands' weight-loss figures happened to be verified on the same day, 2026-09-12, so the dollar comparison on this page is unusually clean. A floor is the lowest dated figure our record holds for that brand and category, never a quote for you.

MEDVi's $179 is handled throughout as a first month rather than a price, because that is what its own label says it is. The $149 and $50 gaps are simple subtraction between two published ongoing figures; we publish no annualised totals and no projections built on an introductory rate.

The warning letter paragraph reports the agency's own findings and gives the fda.gov permalink. We paraphrase the marketing language the FDA quoted rather than reprinting it. Our 9.2 scores are our own editorial assessment; the Trustpilot numbers are third party and dated to the day we observed them.

There is no efficacy content here, no dosing guidance and no list of who a medication suits or does not suit. That last omission is deliberate: deciding a medication against your own body and history is a clinician's job.

Fridays' own listing carries a second, lower semaglutide figure of $117 a month alongside a promotional offer with discount codes, and it is published without a verification date. The figures we quote for Fridays are the dated ones from its price listing, verified on 2026-09-12. If you see $117 advertised, that is the annual-plan price with discount code NYNY12 applied, which we confirmed on joinfridays.com on 2026-10-08. The $150 we quote is the annual-plan price with no code, and a code-conditioned price can be withdrawn at any time.

Final Verdict: Medvi vs Fridays

Where this lands

On price alone, Fridays wins on both of its tiers. Its month-to-month figure of $249 undercuts MEDVi's $299 ongoing price by $50, and its prepaid figure of $150 undercuts it by $149. Both sides were verified on 2026-09-12.

On the regulatory record, MEDVi is the one with something to read. It has an FDA warning letter on its record citing misbranding, issued 2026-02-20 and linked in full above, which the agency's index still shows with no response letter and no close-out letter. That is a fact about the company, not a prediction about your prescription.

What MEDVi does offer that our Fridays file does not is included dietician visits and care coaching, plus a metabolic report in our fit notes, and a flat cash price with insurance kept out of it. Fridays goes the other way with an insurance concierge. If you have coverage worth chasing, that is a genuine reason to look at Fridays first; if you do not, MEDVi's flat-rate framing is the simpler arrangement.

Both weight-loss routes here are compounded. Compounded medications are not FDA-approved as finished drug products: the FDA has not reviewed them for safety, quality or effectiveness.

Visit MedviVisit Fridays

Frequently Asked Questions

How much is MEDVi per month after the first month?

$299 per month, as of 2026-09-12. The $179 figure applies to the first month only, and the ongoing price is what you should plan around. $299 is a floor, meaning the lowest ongoing configuration we could verify on that date.

Which is cheaper month to month, MEDVi or Fridays?

Fridays, on both of its tiers. Its compounded semaglutide is $249 per month month-to-month against MEDVi's $299 ongoing, a $50 gap, and $150 per month on a prepaid plan, a $149 gap. Both were verified on 2026-09-12 and both are floors rather than quotes.

Does MEDVi charge a membership fee on top of the medication?

Our record holds no separate membership charge for MEDVi. We did not independently work through its checkout, so treat that as what our record holds rather than something we tested, and confirm it before you pay.

What is the FDA warning letter against MEDVi about?

On 2026-02-20 the FDA issued MEDVi, LLC a warning letter citing misbranding under sections 502(a) and 502(bb) of the Federal Food, Drug, and Cosmetic Act. Reviewing medvi.io in December 2025, the agency said labels bearing the MEDVi name implied MEDVi compounds the drugs when it does not, and that two lines on the site asserted an equivalence between its compounded product and named brand-name medicines, implying an approval a compounded drug does not hold. MEDVi says medvi.io is affiliate-operated rather than company-operated; we could not verify that, and the letter is addressed to MEDVi, LLC. Its MARCS-CMS number and the full text are given in the section above.

Is the semaglutide Fridays prescribes a brand-name medication?

No. Fridays' published label describes compounded semaglutide and compounded tirzepatide, and our record holds no brand-name option for it. Compounded medications are not FDA-approved as finished drug products: the FDA has not reviewed them for safety, quality or effectiveness.

Does either plan include nutrition or coaching support?

MEDVi's feature list includes free dietician visits and care coaching, plus a metabolic report and one-to-one guidance in our fit notes. Our Fridays record names an insurance concierge and a custom plan, and no dietician. That absence is a gap in our file rather than a finding about Fridays, so ask them directly if nutrition support matters to you.

Sources & References

Our comparisons are informed by official sources and regulatory guidelines. We encourage you to verify information with authoritative sources.

    Editorial Note: Researched and edited by our editorial team. AI tools assist with initial research and drafting; all content is fact-checked and edited by humans before publication. Learn more about our editorial standards

    Related Comparisons

    HimsVSMedviHimsVSFridaysHersVSMedviHersVSFridaysRoVSMedviRoVSFridays

    Start With a Top Weight Loss Provider

    Our Top Choice
    1
    TrimRx logo

    GLP-1 Weight Loss From $179/mo - Free 2-Minute Assessment

    • Compounded GLP-1 (semaglutide) from $179/mo, GLP-1 + GIP (tirzepatide) from $259/mo
    • Brand-name Ozempic®, Mounjaro®, Zepbound® and Wegovy® also available
    • Free 2-minute qualification quiz and FREE doctor consultation - no cost, no obligation
    • Free tracked shipping straight to your door after approval
    TrimRx displays LegitScript certificate 31417191, checked September 19, 2026Cert. 31417191September 19, 2026
    9.4
    OutstandingScore based on review by ManyTreatments editors, popularity, brand reputation, features and benefitsLearn how we score
    ★★★★★
    See PricingRead full review
    Most Popular
    2
    Medvi logo

    No Separate Membership Fee Listed on the Compounded Semaglutide Plan (Checked Sep 2026)

    • Doctor-guided compounded GLP-1 care, 100% online. Compounded medications are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness, or quality.
    • Free dietician visits and care coaching included with your plan
    • Doctor-formulated plans adjusted as your body responds
    • Fast, discreet shipping to your door
    LegitScript lists Medvi as certified, checked on LegitScript's status page September 20, 2026CertifiedSeptember 20, 2026
    9.2
    OutstandingScore based on review by ManyTreatments editors, popularity, brand reputation, features and benefitsLearn how we score
    ★★★★★
    See PricingRead full review
    3
    Fridays logo

    Compounded Semaglutide From $150/mo on Prepaid Plans

    • Compounded semaglutide from $150/mo, tirzepatide from $240/mo on prepaid plans
    • Insurance concierge works to maximize your coverage
    • GLP-1 microdosing option and a custom plan in under 3 minutes
    Fridays displays LegitScript certificate 18528873, checked September 19, 2026Cert. 18528873September 19, 2026
    9.2
    OutstandingScore based on review by ManyTreatments editors, popularity, brand reputation, features and benefitsLearn how we score
    ★★★★★
    See PricingRead full review

    Related Resources

    Brand Review

    Medvi Review

    Brand Review

    Fridays Review

    Brand Review

    Is Medvi Legit?

    Brand Review

    Is Fridays Legit?

    Guide

    Medvi Alternatives

    Guide

    Fridays Alternatives

    Eric Gold
    Eric GoldEditor-in-Chief

    Eric Gold is a writer and editor with a background in digital media and consumer research. He has spent the last several years covering the health and wellness industry, with a particular focus on telehealth services and direct-to-consumer healthcare. Eric believes that access to clear, unbiased information should not require a medical degree. When he is not reviewing telehealth platforms, he enjoys hiking, cooking, and following the stock market a little too closely.

    Medical Disclaimer: The information on this page is for educational purposes only and is not medical advice. Always consult with a licensed healthcare provider before starting any treatment. Read our full medical disclaimer.

    How we scoreOur 1 to 10 brand scores are our own editorial judgment. They are not aggregated from third-party review platforms and they are not the output of a scoring formula.

    What a starting price isA starting price is the lowest figure a company lists for a category, not a quote. What you pay follows a clinician's review of your intake, and where a required membership or care plan sits alongside the medication we publish the two charges combined.

    Reading a warning letterA close-out letter is FDA's record that it has evaluated a company's corrective actions, so the absence of one means the file is not closed on the public record, and nothing more than that.

    Regulatory noticeRegulatory note (verified October 8, 2026): On February 20, 2026 the FDA issued MEDVi, LLC a warning letter (MARCS-CMS 721455) citing misbranding under sections 502(a) and 502(bb) of the FD&C Act. Reviewing medvi.io in December 2025, the FDA said labels bearing "MEDVi" implied MEDVi compounds the drugs when it does not, and that site copy presenting the compounded drug as having the same active ingredient as Wegovy and Ozempic, and as Mounjaro and Zepbound, implied an FDA approval compounded drugs do not have. The letter adds that introducing or delivering the products it identifies into interstate commerce is a prohibited act under section 301(a), that receiving them in interstate commerce and delivering or offering to deliver them also violates section 301(c), and that a compounded drug product must meet the conditions of section 503A or 503B of the FD&C Act to be exempt from certain requirements, including the new drug approval requirements. When we checked FDA's warning letter index for MEDVi, LLC on October 8, 2026 it showed no response letter and no close-out letter entered against it, so the letter is not closed out on the public record. MEDVi states medvi.io is affiliate-operated rather than company-operated; we could not verify that, and the letter is addressed to MEDVi, LLC. Read the FDA letter